UnitedHealth Group (NYSE:UNH) Stock Sale Revealed by Rep. Maria Elvira Salazar

Representative Maria Elvira Salazar (Republican-Florida) recently sold shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on October 7th, the Representative disclosed that they had sold between $1,001 and $15,000 in UnitedHealth Group stock on September 24th. The trade occurred in the Representative’s “UBS IRA ACCOUNT” account.

Representative Maria Elvira Salazar also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Citigroup (NYSE:C) on 9/24/2026.
• Sold $1,001 – $15,000 in shares of Chubb (NYSE:CB) on 9/24/2026.
• Sold $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 9/24/2026.
• Sold $1,001 – $15,000 in shares of GE Aerospace (NYSE:GE) on 9/24/2026.
• Sold $1,001 – $15,000 in shares of Honeywell International (NASDAQ:HON) on 9/24/2026.
• Sold $1,001 – $15,000 in shares of Snowflake (NYSE:SNOW) on 9/24/2026.
• Sold $1,001 – $15,000 in shares of FedEx (NYSE:FDX) on 9/24/2026.
• Sold $1,001 – $15,000 in shares of Salesforce (NYSE:CRM) on 9/24/2026.
• Sold $1,001 – $15,000 in shares of RH (NYSE:RH) on 9/24/2026.
• Sold $1,001 – $15,000 in shares of Meta Platforms (NASDAQ:META) on 9/24/2026.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $370.54 on Friday. The firm has a 50 day moving average of $389.50 and a 200-day moving average of $380.30. UnitedHealth Group Incorporated has a 1 year low of $255.96 and a 1 year high of $461.62. The stock has a market capitalization of $332.59 billion, a P/E ratio of 23.84, a price-to-earnings-growth ratio of 1.41 and a beta of 0.60. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.94 by $1.44. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The firm had revenue of $112.03 billion during the quarter, compared to the consensus estimate of $110.81 billion. During the same quarter in the previous year, the company posted $4.08 EPS. The business’s revenue for the quarter was up .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 19.85 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were paid a $2.32 dividend. The ex-dividend date was Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group’s payout ratio is 59.72%.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the stock. Mizuho boosted their target price on shares of UnitedHealth Group from $470.00 to $493.00 and gave the stock an “outperform” rating in a research note on Monday, July 20th. Barclays boosted their price objective on shares of UnitedHealth Group from $429.00 to $441.00 and gave the stock an “overweight” rating in a research report on Monday, July 20th. New Street Research set a $402.00 target price on UnitedHealth Group in a research note on Friday. Morgan Stanley upped their price target on UnitedHealth Group from $468.00 to $529.00 and gave the company an “overweight” rating in a research note on Friday, July 17th. Finally, Oppenheimer boosted their price objective on UnitedHealth Group from $420.00 to $500.00 and gave the stock an “outperform” rating in a report on Friday, July 17th. Twenty research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and an average price target of $463.55.

Hedge Funds Weigh In On UnitedHealth Group

Hedge funds have recently added to or reduced their stakes in the stock. Wellington Altus USA Inc. raised its position in shares of UnitedHealth Group by 97.1% in the 2nd quarter. Wellington Altus USA Inc. now owns 67 shares of the healthcare conglomerate’s stock valued at $28,000 after acquiring an additional 33 shares during the period. Security National Bank of SO Dak acquired a new stake in UnitedHealth Group in the second quarter worth $29,000. Aberdeen Wealth Management LLC bought a new stake in shares of UnitedHealth Group in the 2nd quarter valued at $31,000. Nalls Sherbakoff Group LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at about $27,000. Finally, Lifetime Wealth Management P.C. bought a new stake in shares of UnitedHealth Group in the fourth quarter worth about $29,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth is scheduled to report third-quarter 2026 results before the market opens on October 13. Analysts expect earnings of approximately $4.12–$4.15 per share on revenue of about $111.38 billion, with some forecasts calling for roughly 41% year-over-year EPS growth. Improving cost management and restructuring could provide an upside surprise. UnitedHealth Gears Up for Q3 Earnings
• Positive Sentiment: Several valuation-focused reports suggest UNH may look inexpensive after its difficult multi-year performance and reset price-to-earnings multiple. The company’s full-year 2026 EPS guidance remains $19.50–$20.00, supporting the argument that the current valuation could offer recovery potential if earnings stabilize. UnitedHealth’s P/E Has Reset
• Neutral Sentiment: A Medicare rate decision is being viewed as a potentially stabilizing factor for UnitedHealth, but investors will likely need more clarity from the earnings report on reimbursement trends, enrollment and medical-cost ratios. Medicare Rate Decision and UnitedHealth
• Negative Sentiment: TD Cowen lowered its price target for UnitedHealth to $402, signaling more cautious expectations even though the target remains above the current trading level. TD Cowen Lowers UnitedHealth Price Target
• Negative Sentiment: UNH is testing technical support ahead of earnings, while at least one analysis has downgraded the stock’s recovery outlook. Investors remain concerned about elevated healthcare costs and whether earnings improvement can be sustained. UnitedHealth Stock Testing Key Support

Insider Transactions at UnitedHealth Group

In related news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the sale, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This represents a 7.09% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.19% of the company’s stock.

About Representative Salazar

Maria Elvira Salazar (Republican Party) is a member of the U.S. House, representing Florida’s 27th Congressional District. She assumed office on January 3, 2021. Her current term ends on January 3, 2027.

Salazar (Republican Party) ran for re-election to the U.S. House to represent Florida’s 27th Congressional District. She won in the general election on November 5, 2024.

Maria Elvira Salazar was born in Miami, Florida, and lives in Coral Gables, Florida. Salazar earned an undergraduate degree from the University of Miami in 1983 and a graduate degree from Harvard University in 1995. Her career experience includes working as a television journalist, reporter, and news anchor.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.